Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Gynaecological, Neuro-oncology and Orphan Cancer

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Serious adverse events · women with persistent, recurrent, or metastatic cervical cancer

Pazopanib showed no clear difference in serious adverse events compared with lapatinib (low certainty).

1 finding from 1 review

Serious adverse events · women with persistent, recurrent, or metastatic cervical cancer

Pazopanib plus lapatinib showed no clear difference in serious adverse events compared with lapatinib (low certainty).

1 finding from 1 review